APGAVI

Live / Registered — Registered (as of 14 Mar 2023)

What this means for you

Registered since 14 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90165171
Registration number
6998642
Mark type
Stylized text
Filed
08 Sept 2020
Published for opposition
27 Dec 2022
Registered
14 Mar 2023
Attorney of record
Kathryn E. Smith

Goods and services

  • Class 005 — Pharmaceuticals: Medicines for dental purposes; Chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antibiotics; Injectable medicines for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Medicine in tablet form for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs sold in bulk for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antiseptics; Collyrium; Hemorrhoidal suppositories, laxative suppositories, or vaginal suppositories for the prevention and treatment of infections; Medical paster, namely, medical plasters; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Medicated sweets; Candy for medical purposes; Dietetic foods adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic preparations adapted for medical purposes; Medicinal oils; Mineral food supplements; Nutritional supplements; Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Radioactive substances for medical purposes; Gases for medical purposes, namely, nitric oxide for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants; Solutions for contact lenses; Media for bacteriological cultures; Depuratives for the body; Diagnostic preparations for veterinary purposes; Pesticides; Sanitary napkins; Cotton for medical purposes; Dental abrasives; Diapers for pets

Owner

Prosecution history

  • 02 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 14 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 14 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
  • 27 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 27 Dec 2022 — PUBLISHED FOR OPPOSITION
  • 07 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 21 Nov 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 21 Oct 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 20 Oct 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 20 Oct 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 09 Jun 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 09 Jun 2022 — NON-FINAL ACTION E-MAILED
  • 09 Jun 2022 — NON-FINAL ACTION WRITTEN
  • 18 May 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 18 May 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE

View this trademark record on Marksy